208 related articles for article (PubMed ID: 15889278)
1. A novel mutation in the PTPN11 gene in a patient with Noonan syndrome and rapidly progressive hypertrophic cardiomyopathy.
Takahashi K; Kogaki S; Kurotobi S; Nasuno S; Ohta M; Okabe H; Wada K; Sakai N; Taniike M; Ozono K
Eur J Pediatr; 2005 Aug; 164(8):497-500. PubMed ID: 15889278
[TBL] [Abstract][Full Text] [Related]
2. PTPN11 gene mutations: linking the Gln510Glu mutation to the "LEOPARD syndrome phenotype".
Digilio MC; Sarkozy A; Pacileo G; Limongelli G; Marino B; Dallapiccola B
Eur J Pediatr; 2006 Nov; 165(11):803-5. PubMed ID: 16733669
[TBL] [Abstract][Full Text] [Related]
3. PTPN11 mutations and genotype-phenotype correlations in Noonan and LEOPARD syndromes.
Ogata T; Yoshida R
Pediatr Endocrinol Rev; 2005 Jun; 2(4):669-74. PubMed ID: 16208280
[TBL] [Abstract][Full Text] [Related]
4. PTPN11 (protein tyrosine phosphatase, nonreceptor type 11) mutations and response to growth hormone therapy in children with Noonan syndrome.
Ferreira LV; Souza SA; Arnhold IJ; Mendonca BB; Jorge AA
J Clin Endocrinol Metab; 2005 Sep; 90(9):5156-60. PubMed ID: 15956085
[TBL] [Abstract][Full Text] [Related]
5. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome.
Tartaglia M; Mehler EL; Goldberg R; Zampino G; Brunner HG; Kremer H; van der Burgt I; Crosby AH; Ion A; Jeffery S; Kalidas K; Patton MA; Kucherlapati RS; Gelb BD
Nat Genet; 2001 Dec; 29(4):465-8. PubMed ID: 11704759
[TBL] [Abstract][Full Text] [Related]
6. PTPN11 mutation in a large family with Noonan syndrome and dizygous twinning.
Schollen E; Matthijs G; Gewillig M; Fryns JP; Legius E
Eur J Hum Genet; 2003 Jan; 11(1):85-8. PubMed ID: 12529711
[TBL] [Abstract][Full Text] [Related]
7. Mek Inhibitor Reverses Hypertrophic Cardiomyopathy in RIT1 Mutated Noonan Syndrome: For the first time, hypertrophic cardiomyopathy was reversed in Noonan syndrome associated with a RIT1 mutation.
Am J Med Genet A; 2019 Aug; 179(8):1408-1409. PubMed ID: 31355539
[No Abstract] [Full Text] [Related]
8. [Gene mutation and clinical phenotype analysis of patients with Noonan syndrome and hypertrophic cardiomyopathy].
Liu XH; Ding WW; Han L; Liu XR; Xiao YY; Yang J; Mo Y
Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):780-784. PubMed ID: 29050118
[No Abstract] [Full Text] [Related]
9. Severe aortic valvar stenosis in familial Noonan syndrome with mutation of the PTPN11 gene.
Abadir S; Edouard T; Julia S
Cardiol Young; 2007 Feb; 17(1):95-7. PubMed ID: 17184563
[TBL] [Abstract][Full Text] [Related]
10. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy.
Pandit B; Sarkozy A; Pennacchio LA; Carta C; Oishi K; Martinelli S; Pogna EA; Schackwitz W; Ustaszewska A; Landstrom A; Bos JM; Ommen SR; Esposito G; Lepri F; Faul C; Mundel P; López Siguero JP; Tenconi R; Selicorni A; Rossi C; Mazzanti L; Torrente I; Marino B; Digilio MC; Zampino G; Ackerman MJ; Dallapiccola B; Tartaglia M; Gelb BD
Nat Genet; 2007 Aug; 39(8):1007-12. PubMed ID: 17603483
[TBL] [Abstract][Full Text] [Related]
11. Noonan Syndrome Case Report: PTPN11 and Other Potential Genetic Factors Contributing to Lethal Hypertrophic Right Ventricular Cardiomyopathy.
Daoud E; Zwick D
Pediatr Dev Pathol; 2019; 22(4):386-390. PubMed ID: 30665336
[TBL] [Abstract][Full Text] [Related]
12. PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome.
Binder G; Neuer K; Ranke MB; Wittekindt NE
J Clin Endocrinol Metab; 2005 Sep; 90(9):5377-81. PubMed ID: 15985475
[TBL] [Abstract][Full Text] [Related]
13. Protein-tyrosine phosphatase, nonreceptor type 11 mutation analysis and clinical assessment in 45 patients with Noonan syndrome.
Yoshida R; Hasegawa T; Hasegawa Y; Nagai T; Kinoshita E; Tanaka Y; Kanegane H; Ohyama K; Onishi T; Hanew K; Okuyama T; Horikawa R; Tanaka T; Ogata T
J Clin Endocrinol Metab; 2004 Jul; 89(7):3359-64. PubMed ID: 15240615
[TBL] [Abstract][Full Text] [Related]
14. The spectrum of cardiac anomalies in Noonan syndrome as a result of mutations in the PTPN11 gene.
Sznajer Y; Keren B; Baumann C; Pereira S; Alberti C; Elion J; Cavé H; Verloes A
Pediatrics; 2007 Jun; 119(6):e1325-31. PubMed ID: 17515436
[TBL] [Abstract][Full Text] [Related]
15. A new PTPN11 mutation in juvenile myelomonocytic leukaemia associated with Noonan syndrome.
Giovannini L; Cavé H; Ferrero-Vacher C; Boutte P; Sirvent N
Acta Paediatr; 2005 May; 94(5):636-7. PubMed ID: 16188759
[No Abstract] [Full Text] [Related]
16. PTPN11 gene analysis in 74 Brazilian patients with Noonan syndrome or Noonan-like phenotype.
Bertola DR; Pereira AC; Albano LM; De Oliveira PS; Kim CA; Krieger JE
Genet Test; 2006; 10(3):186-91. PubMed ID: 17020470
[TBL] [Abstract][Full Text] [Related]
17. Familial aggregation of genetically heterogeneous hypertrophic cardiomyopathy: a boy with LEOPARD syndrome due to PTPN11 mutation and his nonsyndromic father lacking PTPN11 mutations.
Digilio MC; Pacileo G; Sarkozy A; Limongelli G; Conti E; Cerrato F; Marino B; Pizzuti A; Calabrò R; Dallapiccola B
Birth Defects Res A Clin Mol Teratol; 2004 Feb; 70(2):95-8. PubMed ID: 14991917
[TBL] [Abstract][Full Text] [Related]
18. Co-occurrence of hypertrophic cardiomyopathy and myeloproliferative disorder in a neonate with Noonan syndrome carrying Thr73Ile mutation in PTPN11.
Yagasaki H; Nakane T; Hasebe Y; Watanabe A; Kise H; Toda T; Koizumi K; Hoshiai M; Sugita K
Am J Med Genet A; 2015 Dec; 167A(12):3144-7. PubMed ID: 26286251
[TBL] [Abstract][Full Text] [Related]
19. PTPN11 mutation associated with aortic dilation and hypertrophic cardiomyopathy in a pediatric patient with Noonan syndrome.
Jefferies JL; Belmont JW; Pignatelli R; Towbin JA; Craigen WJ
Pediatr Cardiol; 2010 Jan; 31(1):114-6. PubMed ID: 19795160
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukemia in an adult Noonan syndrome patient with PTPN11 mutation.
Matsubara K; Yabe H; Ogata T; Yoshida R; Fukaya T
Am J Hematol; 2005 Jun; 79(2):171-2. PubMed ID: 15929108
[No Abstract] [Full Text] [Related]
[Next] [New Search]
